Literature DB >> 8162049

Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1)

N Fairweather1, C Bell, S Cochrane, J Chelly, S Wang, M L Mostacciuolo, A P Monaco, N E Haites.   

Abstract

X-linked dominant Charcot-Marie-Tooth disease (CMTX1) is a peripheral neuropathy which maps to Xq13 and is flanked by the loci DXS106 (Xq11.2-q12) and DXS559 (Xq13.1). Contained within this interval of approximately 2-3Mb of DNA is the gene, connexin 32 (locus designation GJ beta 1). This gene encodes a gap junction protein which is expressed in large quantities within the liver and throughout a range of other mammalian tissues. We have sequenced the coding region of exon 2 of this gene from affected individuals in nine families with CMTX 1 and have found mutations which segregate with the disease in eight of these families. The mutations detected include missense point mutations at codons 15, 60, 63, 208, and 215, a nonsense point mutation at codon 220, deletions of one base in codon 72/3 producing a stop codon 12 codons down stream and a three base pair deletion which can be predicted to result in the loss of a single amino acid. These findings are consistent with the disease CMTX1 being the result of mutations affecting the gene connexin 32 (Cx32).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162049     DOI: 10.1093/hmg/3.1.29

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

Review 1.  Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways.

Authors:  Vivian Su; Kimberly Cochrane; Alan F Lau
Journal:  J Membr Biol       Date:  2012-07-08       Impact factor: 1.843

2.  Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.

Authors:  C K Abrams; M M Freidin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Brain Res       Date:  2001-05-04       Impact factor: 3.252

Review 3.  Genetic aspects of Charcot-Marie-Tooth disease.

Authors:  C Bell; N Haites
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

4.  Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.

Authors:  C Ressot; D Gomès; A Dautigny; D Pham-Dinh; R Bruzzone
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

5.  Exclusion of three candidate genes, Grpr, Cxn33, and Pdha1, for the X-linked cataract gene on the distal region of the mouse chromosome X.

Authors:  E Zhou; J Favor; W Silvers; D Stambolian
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

Review 6.  The genetic contribution to the phenotype.

Authors:  U Wolf
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

7.  Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations.

Authors:  C Castro; J M Gómez-Hernandez; K Silander; L C Barrio
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.

Authors:  Y Omori; M Mesnil; H Yamasaki
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

Review 9.  Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.

Authors:  G J Snipes; U Suter
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

10.  Altered trafficking of mutant connexin32.

Authors:  S M Deschênes; J L Walcott; T L Wexler; S S Scherer; K H Fischbeck
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.